Evaluation status available after sign-in
About the journal
Discover Oncology is an open-access journal published by Springer in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,990 EUR. Declared review time at DOAJ: 5 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer
- ISSN
- 2730-6011
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,990 EUR
- Articles in DOAJ
- 4945
- Declared review time
- 5 weeks
- Declared peer-review model
- other
- Official website
- https://www.springer.com/journal/12672/
Index listings
- DOAJ · 2021-07-21
- PUBMED · 2021-01-26
- Indexing
- DOAJ · PUBMED
- APC
- 1,990 EUR
- Declared review time (DOAJ)
- 5 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
4945
Most recent article
last month
Average review time (journal-declared via DOAJ)
5weeks
Works in OpenAlex
4925
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
33
i10-index
363
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2021-07-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 13%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101775142
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
- Cancer-related molecular mechanisms research
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Breast Cancer Treatment Studies
Show all subjects (75)
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Lung Cancer Research Studies
- Head and Neck Cancer Studies
- Immune cells in cancer
- Genetic Associations and Epidemiology
- Immune cells in cancer
- Cancer, Hypoxia, and Metabolism
- RNA modifications and cancer
- MicroRNA in disease regulation
- RNA modifications and cancer
- Glioma Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Single-cell and spatial transcriptomics
- MicroRNA in disease regulation
- Single-cell and spatial transcriptomics
- Gastric Cancer Management and Outcomes
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Glioma Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Glioma Diagnosis and Treatment
- scientometrics and bibliometrics research
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Circular RNAs in diseases
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Immune cells in cancer
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- RNA modifications and cancer
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Sarcoma Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Radiomics and Machine Learning in Medical Imaging
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Head and Neck Cancer Studies
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Radiomics and Machine Learning in Medical Imaging
- Head and Neck Cancer Studies
- Lung Cancer Research Studies
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Research Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Esophageal Cancer Research and Treatment
- Breast Cancer Treatment Studies
- Immunotherapy and Immune Responses
- Bladder and Urothelial Cancer Treatments
- Immunotherapy and Immune Responses
- Esophageal Cancer Research and Treatment
- Bladder and Urothelial Cancer Treatments
Keywords (DOAJ)
- cancer
- oncology
- clinical oncology
- cancer cell biology
- oncogenesis
- tumours
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ